Nucleic Acid Therapeutics Successes Milestones And Upcoming As vice president of nucleic acids and nanomedicine at cytiva, he oversaw the integration of precision nanosystems into cytiva, and is expanding solutions for mrna, lipid nanoparticles, and advanced therapies. Delighted to share how we are investing in our dedicated nucleic acid therapeutics team here at cytiva. the team has deep domain expertise in supporting oligonucleotide and mrna based.
Scott Ripley Tonkin Parts Center Scott ripley, phd, is the general manager, nucleic acid therapeutics (nat), at cytiva, which is focused on supporting the clinical manufacture of mrna lnp and other nucleic acid–based therapies. We would like to introduce our newly formed business unit at cytiva— nucleic acid therapeutics. at cytiva, the new team is here to support these customers, throughout the manufacturing. So there's a really powerful toolbox that our clients are working with to unlock the promise of nucleic acid based therapeutics and vaccines. our mission in the nucleic acid therapeutics business unit is simple. No matter who’s at the end of your pipeline, scott ripley and our nucleic acid therapeutics team are ready to help you reach them. cytiva.link vxha8 #nucleicacidtherapeutics.
Virtual Issue Nucleic Acid Therapeutics Nucleic Acids Research So there's a really powerful toolbox that our clients are working with to unlock the promise of nucleic acid based therapeutics and vaccines. our mission in the nucleic acid therapeutics business unit is simple. No matter who’s at the end of your pipeline, scott ripley and our nucleic acid therapeutics team are ready to help you reach them. cytiva.link vxha8 #nucleicacidtherapeutics. 🧬 meet scott ripley, our vp of nucleic acids and nanomedicine. he’s shaping how we support lnp based therapeutics and complex nanomedicines—integrating expert guidance from early. Our mission in the nuclear acid therapeutics business unit is simple. it is to support our customers on that entire manufacturing journey from dna template through to final filled product. Great leadership, and one of the best #mrna and #oligos scientific and #regulatoryaffairs teams in the business :). I love working in the nucleic acid therapeutics team at cytiva and we are just as enthusiastic as our customers are about finding breakthrough therapies scott ripley #team.
Comments are closed.